[

pfizer

]

Panama to cash in on vaccine tourism after more than 70% locals get shots

Panama plans to open for tourists and offer them vaccines as more than 70% of the population is expected to have two vaccines by next month. Panama initially lagged peers in its vaccination drive but is now among the regional leaders with 56% of its population fully vaccinated
Panama to cash in on vaccine tourism after more than 70% locals get shots(Photo by Gustavo Sobreira on Unsplash)
Panama to cash in on vaccine tourism after more than 70% locals get shots(Photo by Gustavo Sobreira on Unsplash)
Updated on Sep 23, 2021 07:47 AM IST
Copy Link
Bloomberg | | Posted by Zarafshan Shiraz

Pfizer donates USD 70 million worth Covid-19 treatment drugs to India

Pfizer colleagues at distribution centres in the US, Europe and Asia are hard at work rushing shipments of Pfizer medicines that the Government of India has identified as part of its Covid-19 treatment protocol, the company's Chairman and CEO Albert Bourla said.
Global pharma major Pfizer is sending medicines valued at more than USD 70 million.(Reuters File Photo)
Global pharma major Pfizer is sending medicines valued at more than USD 70 million.(Reuters File Photo)
Published on May 03, 2021 12:46 PM IST
Copy Link
PTI | , New Delhi

Pfizer's oral medicine for Covid-19 could be ready by next year: CEO

The only antiviral currently approved for use against the coronavirus disease (Covid-19) is Remdesivir, which is manufactured by Gilead Sciences. The US Food and Drug Administration (FDA) gave the drug full approval in October after it was granted emergency use authorization in May last year.
The Pfizer logo is seen at their UK commercial headquarters in Walton Oaks, Britain. (REUTERS / Matthew Childs / File Photo)
The Pfizer logo is seen at their UK commercial headquarters in Walton Oaks, Britain. (REUTERS / Matthew Childs / File Photo)
Published on Apr 28, 2021 11:22 AM IST
Copy Link
ANI |

Coronavirus vaccines from Pfizer, BioNTech neutralises Covid-19 Brazil variant

Pfizer has said it believes its current Covid-19 vaccine is highly likely to still protect against the South African variant but is planning to test a third booster dose of it as well as a version retooled specifically to combat the variant in order to better understand the immune response
Coronavirus vaccines from Pfizer, BioNTech neutralises Covid-19 Brazil variant(Twitter/consumerconnekt)
Coronavirus vaccines from Pfizer, BioNTech neutralises Covid-19 Brazil variant(Twitter/consumerconnekt)
Updated on Mar 09, 2021 08:23 AM IST
Copy Link
Reuters |

Israel in deal with Pfizer to speed up vaccine deliveries for data

More 1.7 million Israelis, or about 18% of its population, have already received their first dose of the Pfizer-BioNTech vaccine, a larger proportion than in any other country. Officials had warned that pace would slow with new vaccine supplies not expected before February.
Israel credits its universal health coverage, centralized system and extensive digitized records for enabling the fast distribution and analysis of the vaccine effort.(REUTERS (Representative Image))
Israel credits its universal health coverage, centralized system and extensive digitized records for enabling the fast distribution and analysis of the vaccine effort.(REUTERS (Representative Image))
Published on Jan 08, 2021 03:41 PM IST
Copy Link
By Bloomberg | Posted by Nilavro Ghosh

News updates from Hindustan Times: Union health minister to visit Tamil Nadu tomorrow to review vaccine dry run in state and all the latest news

Here are today’s top news, analysis, and opinion. Know all about the latest news and other news updates from Hindustan Times.
Earlier, the health minister held a meeting with the health ministers, principal secretaries and additional chief secretaries of states and UTs to review the preparedness of the vaccination mock drill in their respective areas.(PTI Photo)
Earlier, the health minister held a meeting with the health ministers, principal secretaries and additional chief secretaries of states and UTs to review the preparedness of the vaccination mock drill in their respective areas.(PTI Photo)
Updated on Jan 07, 2021 09:16 PM IST
Copy Link
Hindustan Times, New Delhi | By hindustantimes.com

Britain working with Pfizer, AstraZeneca to increase vaccine supplies

More than 1.3 million people in the United Kingdom have received one shot of either AstraZeneca’s or Pfizer’s Covid-19 vaccine, but the government needs to be administering around 2 million doses a week to hit its February target.
Britain's health secretary Matt Hancock, speaks at a news conference.(Reuters)
Britain's health secretary Matt Hancock, speaks at a news conference.(Reuters)
Updated on Jan 07, 2021 09:11 PM IST
Copy Link
London | By Reuters | Posted by Mallika Soni

Nearly 20k second doses of Pfizer vaccine given in England before rule change

The figures showed that 19,981 second vaccinations were given between the Dec. 29 and Jan. 3, out of 1.1 million total administered in England. Across the whole of the United Kingdom, 1.3 million doses have been deployed.
While AstraZeneca’s shot was tested with different intervals between doses, Pfizer has said there is no data to demonstrate the efficacy of its first dose after 21 days.(Reuters Photo)
While AstraZeneca’s shot was tested with different intervals between doses, Pfizer has said there is no data to demonstrate the efficacy of its first dose after 21 days.(Reuters Photo)
Updated on Jan 07, 2021 06:35 PM IST
Copy Link
London | By Reuters| Posted by: Harshit Sabarwal

Timeline: How EU filled its basket in Covid-19 vaccine shopping spree

In June, the EU set up a team of experts from the bloc’s 27 member states to negotiate together with vaccine makers the advance purchase of Covid-19 shots, with a budget of about $2.4 billion.
EU officials said vaccine makers were selected on the basis of progress in their trials and of their ability to produce shots for Europe quickly.(AP)
EU officials said vaccine makers were selected on the basis of progress in their trials and of their ability to produce shots for Europe quickly.(AP)
Published on Jan 06, 2021 07:54 PM IST
Copy Link
Brussels | By Reuters | Posted by Kunal Gaurav

Switzerland says residents who want a Covid-19 shot should get one by summer

Switzerland has ordered a total of about 15 million doses, including from other manufacturers whose products have yet to be approved, after setting aside $455 million to buy shots. High global demand from virtually everywhere, combined with limited production, means there is too little to go around.
With 233,000 doses delivered by Pfizer and BioNTech, so far, the country is expecting vaccine deliveries to hit at least 1.5 million doses by the end of February(REUTERS)
With 233,000 doses delivered by Pfizer and BioNTech, so far, the country is expecting vaccine deliveries to hit at least 1.5 million doses by the end of February(REUTERS)
Published on Jan 05, 2021 08:52 PM IST
Copy Link
Zurich | By Reuters | Posted by Ayshee Bhaduri

EU seeks up to 300 million more doses of Pfizer-BioNTech Covid-19 vaccine

The new contract would include 100 million doses, as well as an option for as many as 200 million more, said the people.
Governments across the EU face growing questions over the slow pace of their vaccine rollouts, and shots from other drugmakers such as AstraZeneca Plc won’t be available for weeks at the earliest.(AP file photo)
Governments across the EU face growing questions over the slow pace of their vaccine rollouts, and shots from other drugmakers such as AstraZeneca Plc won’t be available for weeks at the earliest.(AP file photo)
Published on Jan 05, 2021 07:09 PM IST
Copy Link
By Bloomberg | Posted by Deepali Sharma

Covid-19: UK begins immunisation drive of second vaccine, Mexico okays Oxford-AstraZeneca candidate

Israel has become the third country, after the United States and Canada, to approve Moderna’s Covid-19 vaccine, the American drugmaker said on Monday.
Doses of the COVID-19 vaccine developed by Oxford University and U.K.-based drugmaker AstraZeneca at the Princess Royal Hospital in Haywards Heath, England (Gareth Fuller/Pool via AP)
Doses of the COVID-19 vaccine developed by Oxford University and U.K.-based drugmaker AstraZeneca at the Princess Royal Hospital in Haywards Heath, England (Gareth Fuller/Pool via AP)
Updated on Jan 05, 2021 08:54 AM IST
Copy Link
Hindustan Times, New Delhi | By hindustantimes.com | Edited by Karan Manral

Vaccines may not work on South African coronavirus variant: UK scientists

There are currently 60 vaccine candidates in trials, including those that are already being rolled out from AstraZeneca and Oxford, Pfizer and BioNTech, Moderna, Russia’s Sputnik V and China’s Sinopharm.
A nurse prepares a syringe with the Covid-19 Moderna vaccine for a worker of the New York City Fire Department Bureau of Emergency Medical Services (FDNY EMS), amid the coronavirus disease pandemic in the Manhattan borough of New York City.(REUTERS)
A nurse prepares a syringe with the Covid-19 Moderna vaccine for a worker of the New York City Fire Department Bureau of Emergency Medical Services (FDNY EMS), amid the coronavirus disease pandemic in the Manhattan borough of New York City.(REUTERS)
Published on Jan 05, 2021 07:14 AM IST
Copy Link
London | By Reuters | Posted by Arpan Rai

Video of Egypt virus patients’ ICU death stirs controversy

The governor of Sharqia province denied allegations by a relative of one of the patients that the deaths were caused by a lack of oxygen at the government-run intensive care unit treating Covid-19 patients.
An intensive care unit nurse removes medical equipment from the body of a Covid-19 patient who died in the ICU.(Representational image / AP)
An intensive care unit nurse removes medical equipment from the body of a Covid-19 patient who died in the ICU.(Representational image / AP)
Published on Jan 03, 2021 09:37 PM IST
Copy Link
Cairo | By Associated Press | Posted by Kunal Gaurav

Arvind Kejriwal lauds scientists, doctors after approval to 2 Covid-19 vaccines

The Drugs Controller General of India (DCGI) on Sunday approved Oxford Covid-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country.
The approval was granted by the DCGI following the recommendation by the Covid-19 Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO).(HT Photo)
The approval was granted by the DCGI following the recommendation by the Covid-19 Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO).(HT Photo)
Published on Jan 03, 2021 04:00 PM IST
Copy Link
Hindustan Times, New Delhi | By hindustantimes.com| Edited by Susmita Pakrasi

Where are we in the Covid-19 vaccine race?

The World Health Organization on Thursday listed the vaccine for emergency use, in a move seeking to speed access to it in the developing world.
ndia approval of a two-dose version of AstraZeneca’s vaccine, COVISHIELD, which has also been given the green light by Britain, Argentina and El Salvador, is a major win for a shot seen as crucial for mass immunisations.(Sanchit Khanna/HT PHOTO)
ndia approval of a two-dose version of AstraZeneca’s vaccine, COVISHIELD, which has also been given the green light by Britain, Argentina and El Salvador, is a major win for a shot seen as crucial for mass immunisations.(Sanchit Khanna/HT PHOTO)
Updated on Jan 03, 2021 02:52 PM IST
Copy Link
By Reuters | Posted by Deepali Sharma

Mexican doctor hospitalized after receiving Covid-19 vaccine

The doctor was admitted to the intensive care unit of a public hospital in the northern state of Nuevo Leon after she experienced seizures, difficulty breathing and a skin rash.
The health ministry added that the doctor has a history of allergic reactions and said that there is no evidence from clinical trials that anyone has developed an inflammation of the brain after the vaccine’s application.(Reuters file photo)
The health ministry added that the doctor has a history of allergic reactions and said that there is no evidence from clinical trials that anyone has developed an inflammation of the brain after the vaccine’s application.(Reuters file photo)
Published on Jan 02, 2021 10:41 PM IST
Copy Link
Mexico City | By Reuters | Posted by Deepali Sharma

Pfizer, BioNTech to offer Covid vaccine to volunteers who got placebo

Trial participants who received the placebo will have two doses of the investigational vaccine reserved for them within the study, the companies said on the website.
The US Food and Drug Administration and a panel of its outside advisers have expressed concerns over Pfizer’s “unblinding” plan, saying it could make it harder to continue collecting data on safety and effectiveness needed to win full FDA approval of the vaccine.(REUTERS (Representative Image))
The US Food and Drug Administration and a panel of its outside advisers have expressed concerns over Pfizer’s “unblinding” plan, saying it could make it harder to continue collecting data on safety and effectiveness needed to win full FDA approval of the vaccine.(REUTERS (Representative Image))
Published on Jan 02, 2021 09:10 AM IST
Copy Link
By Reuters | Posted by Nilavro Ghosh

Happy Vaccine Year

An SII official said on Thursday at a webinar that the company had already stockpiled 75 million doses. SII’s chief executive Adar Poonawalla on Wednesday said the company will be supplying India and Covax in a 50-50 manner as and when it produces vials.
A healthcare worker make preparations inside a room at a vaccination center set up at a South Delhi Municipal Corp. maternity home ahead of a nationwide trial of a Covid-19 vaccine delivery system in New Delhi, India.(Bloomberg)
A healthcare worker make preparations inside a room at a vaccination center set up at a South Delhi Municipal Corp. maternity home ahead of a nationwide trial of a Covid-19 vaccine delivery system in New Delhi, India.(Bloomberg)
Updated on Jan 02, 2021 04:32 AM IST
Copy Link
Hindustan Times, New Delhi | By Rhythma Kaul

BioNTech founders warn of Covid-19 vaccine supply gaps

The German biotech startup has led the vaccine race but its shot has been slow to arrive in the European Union due to relatively slow approval from the bloc’s health regulator and the small size of the order placed by Brussels.
A next-generation BioNTech vaccine that would keep at higher temperatures could be ready by late summer.(REUTERS)
A next-generation BioNTech vaccine that would keep at higher temperatures could be ready by late summer.(REUTERS)
Published on Jan 01, 2021 03:56 PM IST
Copy Link
Berlin | By Reuters | Posted by Ayshee Bhaduri

Covid-19 vaccine update: Pan-India dry run on Saturday, WHO approves Pfizer’s candidate

The European Union (EU) will review a request by Pfizer’s German partner, BioNTech SE, for an additional vaccine dose from each vial, instead of the five currently approved.
The Pfizer Covid-19 vaccine has been approved by several countries (REUTERS)
The Pfizer Covid-19 vaccine has been approved by several countries (REUTERS)
Updated on Jan 01, 2021 10:58 AM IST
Copy Link
Hindustan Times, New Delhi | By hindustantimes.com | Edited by Karan Manral

Key expert panel meet today to review data on Serum Institute, Bharat Biotech Covid-19 vaccines

The SEC had met a second time on Wednesday to review their EUA application, after UK’s MHRA granted emergency-use approval to the SII Oxford-AstraZeneca vaccine
Representational image.(REUTERS)
Representational image.(REUTERS)
Updated on Jan 01, 2021 09:22 AM IST
Copy Link
Hindustan Times, New Delhi | By Rhythma Kaul

From cargo planes to vans: Here’s how Centre plans to distribute Covid-19 vaccine

On Friday, the subject expert committee under the Central Drugs Standard Control Organisation will meet to consider the emergency-use authorisation application of Pfizer, Serum Institute of India (SII) and Bharat Biotech’s Covaxin.
A ground staff walks past a container kept at the Cargo Terminal 2 of the Indira Gandhi International Airport in New Delhi in this file photo.(Reuters Photo)
A ground staff walks past a container kept at the Cargo Terminal 2 of the Indira Gandhi International Airport in New Delhi in this file photo.(Reuters Photo)
Updated on Jan 01, 2021 08:58 AM IST
Copy Link
Hindustan Times, New Delhi | By hindustantimes.com | Edited by Meenakshi Ray

Elaborate distribution plan on track as India awaits vaccine approval

The vaccines will be stocked at four Government Medical Store Depots (in Karnal, Mumbai, Chennai and Kolkata) and state and regional vaccine stores.
The initial lots of the vaccine will be sent only to government hospitals, public health centres or large private hospitals. The first two priority groups—health care and other frontline workers
The initial lots of the vaccine will be sent only to government hospitals, public health centres or large private hospitals. The first two priority groups—health care and other frontline workers
Published on Dec 31, 2020 11:31 PM IST
Copy Link
Hindustan Times, New Delhi | By Saubhadra Chatterji

Shaheen Bagh’s Bilkis Bano is in Gal Gadot’s list of ‘Personal Wonder Women’

The actor, who was recently seen reprising the titular role in “Wonder Woman 1984”, shared a series of pictures on her Instagram page, acknowledging young girls and women from all walks of life across the globe.
Earlier this year, Bilkis, popularly known as the Shaheen Bagh Dadi, also featured in the Time magazine as one of the 100 most influential people of 2020.(Instagram/gal_gadot)
Earlier this year, Bilkis, popularly known as the Shaheen Bagh Dadi, also featured in the Time magazine as one of the 100 most influential people of 2020.(Instagram/gal_gadot)
Updated on Dec 31, 2020 04:22 PM IST
Copy Link
New Delhi | By Press Trust of India | Posted by Shankhyaneel Sarkar

India likely to start the new year with a Covid vaccine, hints DCGI

The Subject Expert Committee will meet on January 1 to consider the emergency-use authorisation application of Pfizer, Serum Institute of India, and Bharat Biotech’s Covaxin
Representational image.(REUTERS)
Representational image.(REUTERS)
Updated on Dec 31, 2020 02:42 PM IST
Copy Link
Hindustan Times, New Delhi | By Anonna Dutt

Lessons India can learn from the vaccine rollout in other countries

This provides an opportunity to tweak or overhaul protocols in time
The first month of vaccine rollout has not been smooth elsewhere too. In Germany, delays were reported at several sites after temperature logs showed some of the vaccine boxes did not maintain the freezing temperatures required for the Pfizer-BioNTech dose – potentially damaging stocks(AP)
The first month of vaccine rollout has not been smooth elsewhere too. In Germany, delays were reported at several sites after temperature logs showed some of the vaccine boxes did not maintain the freezing temperatures required for the Pfizer-BioNTech dose – potentially damaging stocks(AP)
Updated on Dec 31, 2020 05:42 AM IST
Copy Link

UK to follow new immunisation strategy for Oxford-AstraZeneca Covid-19 vaccine. All you need to know

The Joint Committee on Vaccination and Immunisation (JCVI) has recommended inoculating as many people as possible with the first dose before offering others their second dose.
The JCVI said that the protection is obtained around two weeks after receiving the first dose of AstraZeneca’s Covid-19 vaccine.(REUTERS)
The JCVI said that the protection is obtained around two weeks after receiving the first dose of AstraZeneca’s Covid-19 vaccine.(REUTERS)
Updated on Dec 30, 2020 08:16 PM IST
Copy Link
Hindustan Times, New Delhi | By hindustantimes.com | Edited by Kunal Gaurav

Why AstraZeneca Covid-19 vaccine approval ‘good news for whole world’? UK minister answers

The Phase 3 trials of AstraZeneca’s vaccine across two different dose regimens showed an average efficacy of 70.4%, with no hospitalisations or severe disease observed in the vaccinated groups from three weeks after the first dose.
Serum Institute of India has partnered with AstraZeneca to conduct clinical trials and manufacture the vaccine in India.(AP)
Serum Institute of India has partnered with AstraZeneca to conduct clinical trials and manufacture the vaccine in India.(AP)
Updated on Dec 30, 2020 05:18 PM IST
Copy Link
Hindustan Times, New Delhi | By hindustantimes.com | Edited by Kunal Gaurav

New spike in UK cases as Oxford-AstraZeneca vaccine is approved

There were renewed calls for another lockdown and stopping schools from reopening after the holiday period ends in early January, as the number of new day-cases touched 53,135 on Tuesday evening – more than 10 times that of the April-May peak.
A technician works on the Oxford University's Covid-19 candidate vaccine, known as AZD1222, co-invented by the University of Oxford and Vaccitech in partnership with pharmaceutical giant AstraZeneca.(AFP file)
A technician works on the Oxford University's Covid-19 candidate vaccine, known as AZD1222, co-invented by the University of Oxford and Vaccitech in partnership with pharmaceutical giant AstraZeneca.(AFP file)
Updated on Dec 30, 2020 04:47 PM IST
Copy Link
Hindustan Times, London | By Prasun Sonwalkar , edited by Vinod Janardhanan
SHARE
  • 1
  • 2
  • 3
  • ...
Story Saved
×
Saved Articles
My Reads
Sign out
New Delhi 0C
Sunday, October 17, 2021